ISPOR PUBLISHES NEW TASK FORCE REPORT ON MULTIPLE CRITERIA DECISION ANALYSIS

Published Jan 26, 2016

First of Two Reports Published in Value in Health

Princeton, NJ—January 26, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force,” in the January/February 2016 issue of Value in Health (Volume 19, Issue 1). Health care decisions are complex and can require the assessment of multiple, often conflicting, objectives. As a result, decision makers—whether they are individuals or committees—often have difficulty processing and systematically evaluating relevant information that could inform those decisions. A set of techniques known under the collective heading multiple criteria decision analysis (MCDA), can be useful to evaluate multiple variables (i.e., criteria) and improve the quality of decision making. MCDA has been widely used in other sectors and is now being increasingly applied in health care. However, while there are many MCDA methods available, little guidance exists for how to choose the right technique for a particular problem. To fill this knowledge gap, ISPOR established its Multi-Criteria Decision Analysis in Health Care Decision Making Emerging Good Practices Task Force in 2014. This first MCDA Task Force Report provides readers with an introduction that: 1) defines MCDA, 2) offers examples of its use in different kinds of health care decision making, 3) provides an overview of the principal methods of MCDA, and 4) describes the key steps involved. A second Task Force Report is in development and is scheduled for publication in the March/April 2016 issue of Value in Health. Report 2 will build on the first report by providing recommendations on Emerging Good Practices for conducting MCDA.

###

Related Stories

Rethinking Medication Adherence: A Stakeholder Blueprint

May 12, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a report from its Medication Adherence and Persistence Special Interest Group that provides valuable insights into the perspectives of key stakeholders on interventions to improve medication adherence. The report, “Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions: An ISPOR Report,” was published in the May 2025 issue of Value in Health.

New Research Reveals Surprising Trends in Women's Health Economics Authorship

May 12, 2025

Value in Health, the official journal of ISPOR announced the publication of new research analyzing women's representation in authorship of papers submitted to and published in Value in Health. The report, “How Well Are Women Represented in Authorship in HEOR? An Analysis of Value in Health: An ISPOR Report,” was published in the May 2025 issue of Value in Health.

Redefining Value in Care for Alzheimer's Disease and Dementia

Apr 8, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that provide crucial insights into the complex health economics of Alzheimer's disease and related dementias (ADRD), offering a roadmap for future research and policy as the aging population grows and novel treatments emerge.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×